If you've searched the pharmacy aisle for BV, you've seen boric acid suppositories, probiotics, pH gels, tea tree oil — a whole wall of products promising relief. Here's the honest answer: as of 2026, there is no FDA-approved OTC product that cures bacterial vaginosis. But some OTC options have a role as adjuncts. This is the full evidence breakdown.
Bacterial vaginosis isn't really an infection in the classic sense — it's a shift in the bacterial ecology of the vagina. Healthy vaginas are dominated by lactobacilli that keep the pH acidic (around 3.8 to 4.5). In BV, lactobacilli drop off and anaerobic organisms — especially Gardnerella vaginalis along with Atopobium, Prevotella, and others — overgrow. That shift raises the pH above 4.5, produces the classic "fishy" amine odor, and causes thin gray discharge.
To resolve BV, you have to knock down the anaerobe overgrowth long enough for lactobacilli to recolonize. That's what metronidazole and clindamycin do — they're specifically active against anaerobes. OTC products mostly try to address the downstream effects (pH, odor, symptoms) without touching the bacterial root.
Boric acid has been used for vaginal infections since the early 20th century. Modern evidence, summarized in several PubMed-indexed reviews, supports a limited role as an adjunct for recurrent BV — typically used for 2 to 3 weeks after a metronidazole course. Small trials suggest it may lower recurrence rates in women with frequent BV episodes.
What boric acid does NOT do: clear active BV on its own in a meaningful percentage of cases. Using it instead of antibiotics — especially if you have symptomatic BV — is not supported by CDC, ACOG, or AAFP guidelines.
Important safety notes: boric acid is toxic if swallowed and must be kept away from children and pets. It must not be used during pregnancy (it's a known reproductive toxin at relevant doses). Some people experience watery discharge, local burning, or vaginal irritation.
The theory is sound: if BV is a lactobacilli-deficient state, restoring lactobacilli should help. Clinical trial results are less clean. NIH-indexed reviews find modest benefit for certain strains — particularly Lactobacillus crispatus, L. rhamnosus GR-1, and L. reuteri RC-14 — in preventing BV recurrence after antibiotic treatment. Evidence is weaker for probiotics alone clearing active BV.
Reasonable use: pair an evidence-based probiotic with your metronidazole course, then continue for a few weeks afterward to reduce recurrence. Pick a product that names the strain and guarantees CFU count at expiration.
These lower vaginal pH temporarily, which can reduce fishy odor and discomfort. They do not kill anaerobic bacteria or resolve BV. Useful as symptomatic relief during or after a confirmed antibiotic course if you still have lingering odor. Do not replace antibiotics.
Has laboratory antibacterial activity, including against Gardnerella. Clinical trial evidence in BV is sparse and inconsistent, and concentrated tea tree oil frequently causes contact dermatitis and vaginal irritation. Not recommended by CDC, ACOG, or AAFP. Avoid.
Sometimes suggested in older literature. Modern guidance from ACOG and CDC is clear: douching of any kind worsens BV risk by disrupting the normal flora. Don't douche.
Folk remedies without clinical evidence. Several have been associated with serious adverse events (chemical burns, retained foreign bodies, allergic reactions). Do not insert food items or undiluted acidic liquids into the vagina.
The CDC first-line BV regimens (2021 guidelines) are:
Symptoms typically improve within 2 to 3 days, and cure rates are around 80 to 85 percent at one month. Oral metronidazole comes with a metallic taste and a strict alcohol warning (no alcohol during treatment and for 3 days after). Vaginal gel has much less systemic absorption and fewer GI side effects.
If you have recurrent BV — defined as three or more episodes in 12 months — your provider may recommend a longer or combination regimen. In that setting, a boric acid suppository course (often 600 mg once daily for 2 to 3 weeks after antibiotics) is a reasonable add-on supported by several trials. This should be done under provider guidance, not self-directed.
If you have first-time, symptomatic, non-pregnant BV, skipping antibiotics and going straight to boric acid is not supported by evidence and delays real resolution.
Untreated BV isn't benign. Real-world consequences of letting it sit, per CDC and ACOG:
If BV keeps coming back, this is the evidence-based combination many providers use:
No. Monistat (miconazole) treats yeast infections, not BV. They look similar (discharge, discomfort) but are caused by completely different organisms and need different treatments. Using Monistat for BV will not help and may delay correct treatment. If you're unsure whether you have yeast or BV, a telehealth visit can differentiate.
Sometimes. Up to about 30% of mild cases resolve spontaneously within a few weeks, but waiting has real risks — STIs, PID, and pregnancy complications if you're pregnant. Read our deep dive on waiting vs. treating.
AZO sells a few vaginal care products, mostly pH-balancing. They're symptom-relief products, not cures. The prescription antibiotic is what clears the infection.
At Bidwell Health, the visit is $45 flat and generic metronidazole is usually under $10 with a GoodRx coupon at most pharmacies — total around $55. That's comparable to or cheaper than many OTC boric acid kits, and it resolves the underlying infection.